Lewis William

Lewis William is listed in filings as Chair and CEO at Insmed Incorporated. This profile follows SEC Form 4 activity through Jun 26, 2026, including sale activity. Recent filings connect the profile to Insmed Incorporated (INSM) and NewAmsterdam Pharma Co N.V. (NAMS). The current snapshot covers public activity from Jan 6, 2026 to Jun 26, 2026. Reported amounts are shown as $1.2M to $381.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.